| Name | Title | Contact Details |
|---|
We`re a group of insanely passionate wellness professionals who are lucky enough to do what we love every single day. We help companies increase the health and performance of their workplace by building tailored, high-touch corporate wellness programs. By encouraging employees to engage, challenge themselves and have fun we strive to boost well being not just during work hours, but wherever the other 128 hours of each week may take them.
Cardiostaff Corporation is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MDX/MEDIREX SYSTEMS Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.